Cohlhepp Ryan
Transaction: 08/10/2026
SELL
Change
-18,750
Price
$3.79
Filing
08/12/2026
Type
SELL
Bicara Therapeutics Inc. Common Stock
BCAX • Biotechnology
$23.17
▼ -0.17 (-0.73%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 62%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.49B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 14.58Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 13, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$23.17
Change-0.73%
Shares Out64.36M
Market Cap$1.49B
Enterprise Value$995.14M
52W Range10.29 - 30.99
Beta-0.75
P/E-8.04
P/B3.18
P/FCF-11.03
EV/EBITDA-5.15
EV/FCF-7.36
Price$23.17
Change-0.73%
Shares Out64.36M
Market Cap$1.49B
Enterprise Value$995.14M
52W Range10.29 - 30.99
Beta-0.75
P/E-8.04
P/B3.18
P/FCF-11.03
EV/EBITDA-5.15
EV/FCF-7.36
Earnings Yield-12.43%
FCF Yield-9.07%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio14.58
Quick Ratio14.58
Target$32.57
Target Upside40.57%
Target Median$35.00
Target Range20.00 - 42.00
Volume808.88K
Avg Volume651.83K
EPS Surprise-0.29
Investment DNA
How strong this company looks for long-term investors
46
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
84/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 14.58Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
83/100
Bullish
Bullish
6
Hold
3
Bearish
0
Price Target
2026-08-13
Low
$20.00
Mean
$32.17
Median
$36.00
High
$42.00
Insider Transactions
Recent executive and insider activity
Cohlhepp Ryan
Transaction: 08/10/2026
SELL
Change
-18,750
Price
$27.98
Filing
08/12/2026
Type
SELL
Mazumdar Claire
Transaction: 08/10/2026
SELL
Change
-10,000
Price
$3.79
Filing
08/12/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cohlhepp Ryan | SELL | -18,750 | $3.79 | 08/10/2026 | 08/12/2026 |
| Cohlhepp Ryan | SELL | -18,750 | $27.98 | 08/10/2026 | 08/12/2026 |
| Mazumdar Claire | SELL | -10,000 | $3.79 | 08/10/2026 | 08/12/2026 |
| Mazumdar Claire | SELL | -10,000 | $27.98 | 08/10/2026 | 08/12/2026 |
| Hyep Ivan | SELL | -12,500 | $3.79 | 08/10/2026 | 08/12/2026 |
| Hyep Ivan | SELL | -12,500 | $27.97 | 08/10/2026 | 08/12/2026 |
| Oliger Christy J. | OTHER | 0 | Not reported | 07/28/2026 | 07/29/2026 |
| Bender Jeremy | OTHER | 0 | Not reported | 07/28/2026 | 07/29/2026 |
| Oliger Christy J. | BUY | +38,950 | $26.88 | 07/28/2026 | 07/29/2026 |
| Bender Jeremy | BUY | +38,950 | $26.88 | 07/28/2026 | 07/29/2026 |
| Mazumdar Claire | SELL | -10,000 | $3.79 | 07/10/2026 | 07/14/2026 |
| Mazumdar Claire | SELL | -28 | $29.68 | 07/10/2026 | 07/14/2026 |
| Cohlhepp Ryan | SELL | -536 | $29.00 | 07/09/2026 | 07/10/2026 |
| Hyep Ivan | SELL | -908 | $3.79 | 07/08/2026 | 07/10/2026 |
| Hyep Ivan | SELL | -830 | $30.31 | 07/08/2026 | 07/10/2026 |
| Cohlhepp Ryan | SELL | -18,750 | $3.79 | 07/08/2026 | 07/10/2026 |
| Cohlhepp Ryan | SELL | -1,075 | $30.35 | 07/08/2026 | 07/10/2026 |
| Simson Jake | BUY | +19,475 | $20.56 | 06/09/2026 | 06/10/2026 |
| POWELL MICHAEL | BUY | +19,475 | $20.56 | 06/09/2026 | 06/10/2026 |
| Robertson Scott M. | BUY | +19,475 | $20.56 | 06/09/2026 | 06/10/2026 |